MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia
暂无分享,去创建一个
Tingting Shao | Xuejiao Liu | K. Zhao | Kailin Xu | Rong Wang | Ninghan Zhang | Yao Yao | Linyan Xu | Shengyun Zhu | Mingshan Niu | Yangling Shen | Yuan Feng | K. Xu